Skye Bioscience Ownership | Who Owns Skye Bioscience?


OverviewForecastFinancialsChartTranscripts

Skye Bioscience Ownership Summary


Skye Bioscience is owned by 2.38% institutional investors, 1.39% insiders, and 96.23% retail investors. 5am venture management is the largest institutional shareholder, holding 24.41% of SKYE shares.

SKYE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSkye Bioscience2.38%1.39%96.23%
SectorHealthcare Stocks 232.52%10.72%-143.24%
IndustryBiotech Stocks 384.56%10.59%-295.14%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
5am venture management9.68M24.41%$38.05M
Versant venture management2.01M5.06%$1.51M
Baker bros. advisors lp1.45M3.66%$5.70M
Schonfeld strategic advisors1.19M2.99%$4.67M
Vanguard group882.78K2.23%$662.09K
Driehaus capital management620.39K1.56%$2.44M
Sphera funds management478.93K1.21%$1.88M
Blackrock funding, inc. /de281.84K0.71%$211.30K
Mirae asset global etfs269.73K0.68%$1.06M
Platinum investment management233.09K0.59%$916.06K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
5am venture management9.68M13.94%$38.05M
Versant venture management2.01M1.00%$1.51M
Sphera funds management478.93K0.40%$1.88M
Platinum investment management233.09K0.06%$916.06K
Baker bros. advisors lp1.45M0.04%$5.70M
Schonfeld strategic advisors1.19M0.03%$4.67M
Driehaus capital management620.39K0.02%$2.44M
Boothbay fund management106.27K0.01%$417.64K
R squared14.78K0.01%$11.08K
Bridgeway capital management42.00K0.00%$165.06K

Top Buyers

HolderShares% AssetsChange
Boothbay fund management106.27K0.01%106.27K
Schonfeld strategic advisors1.19M0.03%89.35K
Two sigma investments, lp92.32K0.00%29.16K
Hrt financial lp27.35K0.00%27.35K
Gsa capital partners llp22.88K0.00%22.88K

Top Sellers

HolderShares% AssetsChange
Braidwell lp---825.73K
Ensign peak advisors---767.29K
Alyeska investment group---456.16K
Marshall wace, llp---251.65K
5am venture management9.68M13.94%-231.41K

New Positions

HolderShares% AssetsChangeValue
Boothbay fund management106.27K0.01%106.27K$417.64K
Gsa capital partners llp22.88K0.00%22.88K$17.00K
Barclays21.25K-21.25K$15.93K
Quadrature capital16.41K0.00%16.41K$64.81K
R squared14.78K0.01%14.78K$11.08K

Sold Out

HolderChange
Newedge advisors-1.00
Citigroup-1.00
Principal securities-2.00
Beacon capital management-8.00
Srs capital advisors-9.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202515-76.56%944,297-95.25%20.09%7-68.18%2-89.47%
Sep 30, 202511-80.00%2,945,202-85.48%70.28%5-80.00%1-93.33%
Jun 30, 202559-20.27%20,399,51759.63%514.95%28-3.45%16-15.79%
Mar 31, 2025742.78%12,779,599-49.30%320.68%29-29.27%19111.11%
Dec 31, 202472-4.00%25,208,445-2.03%691.57%41-9-10.00%

Recent Insider Transactions


DateNameRoleActivityValue
Aug 21, 2025Schwab Andrew J. Sell$8.26K
Aug 22, 2025Schwab Andrew J. Sell$22.13K
Aug 22, 2025Schwab Andrew J. Sell$560.81K
Aug 21, 2025Schwab Andrew J. Sell$209.35K
Aug 21, 20255AM Partners VII, LLC-Sell$209.35K

Insider Transactions Trends


DateBuySell
2025 Q3-8
2025 Q2--
2025 Q1--
2024 Q4-10
2024 Q3-12

SKYE Ownership FAQ


Who Owns Skye Bioscience?

Skye Bioscience shareholders are primarily institutional investors at 2.38%, followed by 1.39% insiders and 96.23% retail investors. The average institutional ownership in Skye Bioscience's industry, Biotech Stocks , is 384.56%, which Skye Bioscience falls below.

Who owns the most shares of Skye Bioscience?

Skye Bioscience’s largest shareholders are 5am venture management (9.68M shares, 24.41%), Versant venture management (2.01M shares, 5.06%), and Baker bros. advisors lp (1.45M shares, 3.66%). Together, they hold 33.13% of Skye Bioscience’s total shares outstanding.

Does Blackrock own Skye Bioscience?

BlackRock is not among the top 10 institutional shareholders of Skye Bioscience.

Who is Skye Bioscience’s biggest shareholder by percentage of total assets invested?

5am venture management is Skye Bioscience’s biggest shareholder by percentage of total assets invested, with 13.94% of its assets in 9.68M Skye Bioscience shares, valued at 38.05M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools